Nextgen Healthcare Inc - NXGN STOCK NEWS

NextGen Healthcare (NASDAQ: NXGN) has entered a definitive agreement to acquire TSI Healthcare for $68 million, effective November 30, 2022. The deal includes up to $22 million in contingent earnout based on financial targets through March 31, 2025. This acquisition is expected to boost revenue by $10-$12 million within fiscal 2023 and enhance adjusted EBITDA and cash flow within a year. The integration emphasizes NextGen's expansion into specialties like rheumatology and cardiology, building on a long-standing partnership with TSI Healthcare.

NextGen Healthcare, Inc. (Nasdaq: NXGN) announced participation in the Piper Sandler 34th Annual Healthcare Conference. The management's fireside chat is scheduled for Wednesday, Nov. 30 at 1 p.m. Eastern time. A recording of the event will be accessible on investor.nextgen.com and archived for 90 days. NextGen Healthcare focuses on innovative cloud-based healthcare technology solutions that enhance ambulatory healthcare and improve patient outcomes.

NextGen Healthcare (Nasdaq: NXGN) will participate in the Stephens Annual Investment Conference on November 15 at 3 p.m. Eastern Time. The event will feature a fireside chat format with the company's management. A recording of the session will be accessible at investor.nextgen.com and archived for 90 days post-event. NextGen Healthcare is recognized for its innovative, cloud-based healthcare technology solutions, aiming to enhance clinical quality and patient experience.

NextGen Healthcare, Inc. (NASDAQ: NXGN) successfully held its 25th annual User Group Meeting in Nashville from November 7-9, 2022, attracting around 1,800 healthcare professionals. The conference focused on improving healthcare outcomes through technology. Key speakers included innovation theorist John Nosta and Paralympic medalist Amy Purdy. Four healthcare providers received the 2022 Excellence in Healthcare Awards for their outstanding use of NextGen solutions. The event highlighted NextGen's commitment to advancing healthcare technology and its impact on community health.

NextGen Healthcare, Inc. (Nasdaq: NXGN) commenced its 25th annual User Group Meeting (UGM) in Nashville, attracting nearly 2,000 attendees for the first in-person gathering since 2019. The event, running until Nov. 9, emphasizes the role of technology in enhancing healthcare outcomes and alleviating physician burnout. CEO David Sides highlighted the company's innovative solutions aimed at future healthcare practices. UGM 22 includes over 125 educational sessions, focusing on various aspects like value-based care and financial stability, fostering a collaborative healthcare community.

NextGen Healthcare (Nasdaq: NXGN) has been selected by Cherry Health, Michigan's largest Federally Qualified Health Center, to provide its NextGen Enterprise EHR and practice management solution. The decision followed a thorough evaluation focusing on functionality and integrated solutions to enhance patient-provider interactions. With over 800 healthcare professionals serving more than 65,000 patients annually, Cherry Health aims to alleviate provider burnout and streamline operations using NextGen's customizable platform, which includes tools like Virtual Visits and Managed Cloud Services.

NextGen Healthcare (NASDAQ: NXGN) has priced a private offering of $230 million in 3.75% convertible senior notes due 2027, increased from an initial $200 million. Settlement is set for November 1, 2022. The notes will accrue interest payable semi-annually and grant holders certain conversion rights beginning August 16, 2027. The estimated net proceeds of approximately $222.8 million will be used for general corporate purposes and to repurchase $40 million of its common stock. The initial conversion price is approximately $25.68 per share, reflecting a 35% premium over the last closing price.

NextGen Healthcare (NASDAQ: NXGN) announced plans to offer $200 million in convertible senior notes due 2027 in a private offering aimed at qualified institutional buyers. An additional $30 million could be offered at the purchasers' option. The notes will accrue semi-annual interest and may be converted to cash or stock. Up to $50 million of proceeds will be used to repurchase common stock, potentially affecting share prices. The offering is not registered under the Securities Act. No assurances on final offering terms have been provided.

NextGen Healthcare, Inc. (Nasdaq: NXGN) reported a strong performance for the fiscal second quarter ending September 30, 2022, with total revenue of $159.4 million, up 7% year-over-year. Recurring revenue increased 6% to $143.5 million, while non-recurring revenue rose 17% to $15.9 million. The company achieved a fully diluted net income per share of $0.20, compared to a net loss of $0.10 in the prior year. Revised fiscal 2023 guidance now anticipates revenue of $630 to $640 million and non-GAAP EPS of $0.93 to $0.99.